ABSTRACT
Background@#Myocardial perfusion scintigraphy images with iterative reconstruction showed higher qualitative and quantitative estimates. @*Objective@#This study was conducted to compare image quality, diagnostic accuracy, and LV parameters with standard FBP versus OSEM as baseline quality assurance for the choice of reconstruction algorithm most applicable in the local setting. @*Methods@#This was a retrospective cross-sectional study of 55 Thallium-201 (Tl-201) scans and 14 Techentium-99m sestamibi (Tc-99m) images that were reprocessed with filtered backprojection (FBP) and with ordered subset expectation maximization (OSEM). The image quality, diagnostic accuracy, and LV parameters of both SPECT reconstructions were compared.@*Results@#OSEM reconstruction resulted in a significantly smooth background tracer activity as opposed to the standard FBP in both Tl-201 (p<0.01) and Tc-99m (p=0.01) scans. Distinct LV border was superiorly seen in OSEM. There was no significant difference in the diagnostic accuracy between the two reconstruction parameters despite 2 cases of interpretation discrepancies. End-diastolic volume generated by OSEM was significantly higher (117.60+55.14 vs 118.51+55.11, p<0.01 in Tl-201 and 101.07+75.58 vs 104.29+80.39, p =0.01 in Tc-99m). With Tc-99m scans the end-systolic volume and ejection fraction in OSEM were likewise significantly different from FBP (p=0.04 and p<0.01, respectively).@*Conclusion@#OSEM reconstruction offers smooth background tracer activity with comparable diagnostic accuracy to FBP. All the LV parameters in OSEM were significantly different from FBP in Tc-99m scans and only the EDV in thallium images.
ABSTRACT
BACKGROUND: Serum thyroglobulin assays and I-131 imaging and routinely employed for the detection of remaining functioning thyroid tissue after surgery and radioiodine therapy. However, the sensitivity of I-131 is suboptimal resulting in cases of positive thyroglobulin test but negative I-131 imaging, potentially creating a dilemma in subsequent therapeutic management. Other radiopharmaceuticals, such as TI-201 may offer better sensitivity, although it is not clear whether this contributes to the decision-making for subsequent I-131therapy. This prospective cohort study aimed to determine if Tl-201 imaging identified thyroid tissues that will take up therapeutic I-131, and to help define its clinical utility.METHODS: Fourteen consecutive patients who underwent surgery for well-differentiated thyroid cancer, had I-131 therapy at least eight months previously, and with elevated thyroglobulin (>10 ng/mL) but negative pre-therapy (111 MBq) I-131 whole body scan (WBS), were enrolled in the study. WBS was done using 56.74 MBq of Tl-201. All patients had repeat I-131 ablation (3.7-7.4GBq) one to two months after Tl-201 imaging. Post-therapy WBS was done four to seven days after.RESULTS: All 14 patients had papillary thyroid carcinoma. Ten patients had a positive Tl-201 scan. Of the 14 subjects, only two had a positive post-therapy I-131 WBS, both whom had a positive Tl-201 scan. Thallium-201 scanning showed a fairly high sensitivity (71%) in demonstrating thyroid remnants or metastases using a thyroglobulin level of >10 ng/mL as standard. However, a positivel Tl-201 scan only has a predictive value of 20% for subsequent uptake of therapeutic I-131 as shown in the post-therapy scan.CONCLUSION: Thallium-201 uptake correlates poorly with therapeutic I-131 uptake in thyroglobulin-positive, but I-131 scan-negative, differentiated thyroid cancer patients. Results of this study suggest that the presence of thyroid remnants and metastases on Tl-201 imaging is inappropriate as a basis for subsequent I-131 therapy.
Subject(s)
Humans , Male , Female , Middle Aged , Adult , Thyroglobulin , Thyroid Cancer, Papillary , Radiopharmaceuticals , Iodine Radioisotopes , Thallium , Thyroid Neoplasms , Carcinoma , Neoplasms, Second Primary , Thallium RadioisotopesABSTRACT
OBJECTIVES: Impairment of coronary flow reserve (CFR) precedes preclinical atherosclerosis. However, data are lacking regarding its prognostic utility using SPECT imaging. Thus, this study aimed to determine the clinical utility of CFR by sestamibi imaging in predicting future cardiac events in patients with normal and abnormal myocardial perfusion scan (MPS).METHODS: This was a prospective cohort study of 54 consecutive adult patients with suspected coronary artery disease referred to Nuclear Medicine Division, Philippine Heart Center for dipyridamole technetium-99m sestamibi SPECT MPS from August 2012 to September 2013. Patients with normal (summed stress score, SSS 4) perfusion scans were further subdivided based on their CFR whether normal (CFR> 2) or abnormal (CFR RESULTS: A prospective cohort of 54 consecutive patients with no known CAD, were enrolled in the study. Abnormal MPI revealed significantly lower CFR (1.64 + 0.47 vs. 1.19 + 0.36, p=0.005). The annual cardiac event rate increased in the presence of reduced CFR in spite of a normal MPI (from 0% to 6.9%), and was even higher when both MPI and CFR were abnormal (from 0% to 34.7%). In Kaplan-Meier analysis, patients with abnormal perfusion revealed-significantly higher incidence of cardiac events compared with normal perfusion (chi-square 4.93, p=0.027). There was a trend towards increased incidence of cardiac events in patients with abnormal CFR; however, this did not reach statistical significance (chi-square 0.61, p=0.434).CONCLUSION: A low CFR was associated with an increased incidence of MACE, particularly in the presence of abnormal perfusion findings.